Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-01-23
2000-10-10
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 514 49, 435455, A61K 4800, C12N 1585
Patent
active
061302066
ABSTRACT:
Virus infections promoting Chronic Fatigue can be diagnosed by assessing the 2'-5'A/RNase L pathway, including measurement of 2'-5'A oligonucleotide levels in the patient's circulating peripheral leucocytes, and comparing these resuls with those of healthy individuals. Double-stranded RNAs, notably mismatched dsRNAs, when administered in appropriate amounts, increase the 2'-5'A and normalize the antiviral pathway in patients with Chronic Fatigue Syndrome and improve the clinical symptoms.
REFERENCES:
patent: 4024222 (1977-05-01), Ts'o et al.
patent: 4795744 (1989-01-01), Carter
patent: 4950652 (1990-08-01), Carter
patent: 5063209 (1991-11-01), Carter
Archives of Virology, vol. 91, 1986, D.D. Pekovic et al, "Detection of HTLV-III/LAV Antigens in Peripheral Blood Lymphocytes . . . " pp. 11-19.
Journal of Biological Chemistry, vol. 260, No. 16, Aug. 5, 1985, D. Krause et al, "Independent Regulation of ppp(A2'p) . . . ", pp. 9501-9506.
Carter et al, The Lancet, 1286-1292, Jun. 6, 1987, "Clinical, Immunological, and Virological Effects of Ampligen, A Mismatched Double-Stranded RNA, in Patients with AIDS or AIDS-Related Complex".
Suhadolnik et al: in vivo 8:599-604 (1994) "Changes in the 2-5A Synthetase/RNase L Antiviral etc."
Suhadolnik et al: Clinical Infectious Diseases 1994:1 (suppl. 1): S96-104 "Upregulation of the 2-5A etc."
Suhadolnik et al: J. of Interferon and Cytokine Research 17:377-385 (1997) "Biochemical Evidence for a Novel Low Molecular Weight 1-5A-Dependent RNAse L in Chronic Fatigue Syndrome"
Krause et al. J. Biolog. Chem. vol. 260, No. 16, Aug. 15, 1985, pp. 9501-9506.
Crouch Deborah
HEM Research, Inc.
LandOfFree
Treating viral infections associated with chronic fatigue with d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating viral infections associated with chronic fatigue with d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating viral infections associated with chronic fatigue with d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2257086